Elliot Ehrich, SVP, R&D & CMO, Alkermes, Inc at Alkermes plc. (ALKS), sold 16,667 shares at $47.29 ($790K) on 2014-07-09, disclosed to the SEC on 2014-07-11.
Scheduled sale ($790k) by SVP, R&D & CMO, Alkermes, Inc under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.29 | 14,400 | $681K | 86.2% |
| 2 | $48.17 | 2,267 | $109K | 13.8% |
| Total | $47.41 avg | 16,667 | $790K | 100% |
| Filing → |
| ALKS | SELL | 2017-02-16 | $1.2M | — | Filing → |
| ALKS | SELL | 2017-01-18 | $1.3M | — | Filing → |
| ALKS | SELL | 2017-01-06 | $618K | — | Filing → |